Leveraging Illumina iSeq100 for Whole Genome Sequencing of Salmonella Typhi: a practical approach for resource-limited setting

Nishan Katuwal,Shiva Ram Naga,Aastha Shrestha,Sabin Bikram Shahi,Dipesh Tamrakar,Rajeev Shrestha
DOI: https://doi.org/10.1101/2024.09.22.24314150
2024-10-14
Abstract:Bacterial whole genome sequencing helps to improve our understanding of epidemiology and pathogenesis of bacterial infections and allows comprehensive investigation on virulence, evolution and resistance mechanisms. Nepal, in recent times, has seen some increase in sequencing capabilities but faces numerous hurdles for optimum utilization. However, these hurdles can be alleviated with use of Illumina iSeq100. Therefore, this study aimed at performing whole genome sequencing of bacteria isolated utilizing the iSeq100 platform. For this study, 6 banked Salmonella enterica serovar Typhi bacterial isolates were selected. These isolates were extracted for DNA, confirmed by qPCR and then, their libraries were prepared. The libaries were checked and loaded in Illumina iSeq100 at loading concentration of 200pM. The consensus was generated from the raw genomic data by reference-based assembly, mapping onto S. Typhi CT18. These consensus genomes and coverage parameters were compared to data from using HiSeq and NextSeq. The raw reads were also evaluated using pathogenwatch (v22.3.8) to observe for genotype, mutations and resistance genes. The coverage parameters (coverage width and depth) of the genomes from this study were compared to same genomes sequenced using Illumina HiSeq and NextSeq. The average coverage width (96.81%) and depth (63.75x) of genomes sequenced in iSeq100 were comparable to that of HiSeq (width: 98.72% and depth: 69.87x). When the genomes sequenced were compared, the genotypes detected, number of SNPs and genetic determinants of AMR genes were identical. The data from bacterial whole genome sequencing using the Illumina iSeq100 is equally informative when compared to other high-end sequencers. Therefore, the primary goal of this study is to advocate for optimum utlisation of iSeq100 while still ensuring a high standard of quality. This optimum utilization would create capacity to fill critical surveillance gaps.
Infectious Diseases (except HIV/AIDS)
What problem does this paper attempt to address?
This paper attempts to address the issue of how to utilize the Illumina iSeq100 platform for whole-genome sequencing of Salmonella Typhi in resource-limited settings. Specifically, the study aims to evaluate the feasibility and cost-effectiveness of using the Illumina iSeq100 for bacterial whole-genome sequencing in resource-limited countries (such as Nepal) and to compare it with higher-end sequencing platforms (such as Illumina HiSeq and NextSeq) to validate its data quality and coverage parameters. ### Main Objectives: 1. **Evaluate the performance of Illumina iSeq100**: Validate the capability of iSeq100 for whole-genome sequencing in resource-limited settings by comparing its data quality with HiSeq and NextSeq. 2. **Cost-effectiveness analysis**: Assess the cost-effectiveness of using iSeq100 for whole-genome sequencing, particularly in resource-limited laboratories. 3. **Optimize sequencing workflow**: Explore and optimize the experimental and bioinformatics workflows for using iSeq100 for whole-genome sequencing to improve data quality and reduce costs. ### Background: - **Limitations of traditional methods**: Traditional pathogen characterization methods (such as phenotypic and molecular methods) have limitations in distinguishing closely related strains, resistance, and virulence factors, and are time-consuming and labor-intensive. - **Advantages of whole-genome sequencing**: Whole-genome sequencing (WGS) can provide comprehensive biological information about pathogens, including mutations, drug resistance, transmission, evolution, and epidemiological surveillance. - **Challenges in resource-limited settings**: Countries like Nepal face many obstacles in sequencing capabilities, such as technical complexity, supply chain issues, and funding constraints. ### Methods: - **Sample selection**: Randomly selected 6 stored Salmonella Typhi isolates from the Surveillance for Enteric Fever in Asia Project (SEAP). - **DNA extraction and qPCR confirmation**: Extracted DNA and confirmed samples using qPCR. - **Library preparation and sequencing**: Prepared libraries using the NEBNext Ultra II FS DNA Library Preparation Kit and sequenced on the Illumina iSeq100 platform. - **Data analysis**: Processed, assembled, and aligned raw genome data to generate consensus sequences and evaluated coverage parameters. Used the Pathogenwatch platform to detect genotypes, single nucleotide polymorphisms (SNPs), and antimicrobial resistance genes. ### Results: - **Coverage parameters**: The average coverage breadth of genomes sequenced by iSeq100 was 96.81%, with a coverage depth of 63.75x, comparable to the results from HiSeq and NextSeq. - **Genotypes and resistance genes**: Genomes sequenced by iSeq100 showed consistent results with HiSeq and NextSeq in terms of genotypes, SNPs, and antimicrobial resistance genes. - **Cost analysis**: When sequencing 4 samples in a pooled run, the cost per Gb was approximately $158, while for 2 samples in a pooled run, the cost per Gb was approximately $312. ### Conclusion: - **Data quality**: The bacterial whole-genome sequencing data generated by Illumina iSeq100 is comparable to high-end sequencing platforms (such as HiSeq and NextSeq), with high coverage and accuracy. - **Cost-effectiveness**: iSeq100 is highly cost-effective in resource-limited laboratories, suitable for small-scale whole-genome sequencing. - **Application prospects**: This study provides new tools and methods for clinical microbiology, epidemic surveillance, and antimicrobial resistance monitoring in Nepal and other resource-limited countries. Through these results, the researchers hope to promote the widespread application of Illumina iSeq100 in resource-limited regions, enhancing their capabilities in pathogen surveillance and research.